Stay updated on Prasinezumab in Early Parkinson's Disease Clinical Trial
Sign up to get notified when there's something new on the Prasinezumab in Early Parkinson's Disease Clinical Trial page.

Latest updates to the Prasinezumab in Early Parkinson's Disease Clinical Trial page
- ChecktodayChange DetectedA notice was added announcing an NIH website transition and saying federal agencies are using “Super Intelligence” in place of “Artificial Intelligence” during the transition.SummaryDifference0.3%

- Check7 days agoChange DetectedThe footer revision label changed from v3.7.1 to v3.7.2.SummaryDifference0.0%

- Check14 days agoChange DetectedThe footer’s ClinicalTrials.gov site revision changed from v3.7.0 to v3.7.1.SummaryDifference0.0%

- Check36 days agoChange DetectedThe history section now lists the latest release as Revision: v3.7.0, replacing the previous v3.6.6. This reflects a software update in the page’s versioning metadata rather than a change to trial data or core content.SummaryDifference0.0%

- Check43 days agoChange DetectedRecord history now displays a dedicated Study Status entry for the latest version (v58, 2026-09-09), reflecting current status updates, and an older entry from 2026-07-13 was deleted.SummaryDifference0.2%

- Check57 days agoChange DetectedThe page history now shows a new revision label (v3.6.6) replacing the previous v3.6.5. This indicates a latest update to the study record without altering core content.SummaryDifference0.1%

Stay in the know with updates to Prasinezumab in Early Parkinson's Disease Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Prasinezumab in Early Parkinson's Disease Clinical Trial page.